Literature DB >> 26261531

Protective effects of LM22A-4 on injured spinal cord nerves.

Guangzhe Yu1, Wenbo Wang2.   

Abstract

OBJECTIVE: The goal of this study was to elucidate the protection by and potential mechanisms of LM22A-4, a specific agonist of tyrosine kinase receptor B, against spinal cord injury (SCI).
METHODS: Spinal cord trauma was induced by the application of vascular clips to the dura of mice via a four-level T7-T11 laminectomy. Thirty minutes after the injury, an abdominal injection of LM22A-4 (at dosages of 10 mg/kg and 15 mg/kg) or an equal volume of solvent was provided. Twenty-four hours after SCI, a Western blot was performed to examine the expression of p-TrkB, p-Akt, p-ERK, cleaved-caspase-3, and Bcl-2; a TUNEL assay and Nissl staining were performed to study apoptosis and the survival of neurons. In addition, another batch of mice was allowed to live for 14 days after the SCI treatment, during which the LM22A-4 was provided at the same time each day and the neurological function was assessed.
RESULTS: Spinal cord injury in mice resulted in severe trauma characterized by tissue damage and apoptosis. Treatment of the mice with LM22A-4 (10 mg/kg) significantly reduced the degree of tissue injury (histological score) and apoptosis (TUNEL staining and caspase-3 and Bcl-2 expression) compared with vehicle treated group (P < 0.05). In a separate set of experiments, chronic treatment with LM22A-4 also significantly ameliorated the recovery of limb function (P < 0.05).
CONCLUSION: This study provides an experimental evidence that LM22A-4 reduces the development of tissue injury associated with spinal cord trauma, and activation of the activity of TrkB may represent a novel approach for the therapy of spinal cord trauma.

Entities:  

Keywords:  LM22A-4; SCI

Mesh:

Substances:

Year:  2015        PMID: 26261531      PMCID: PMC4525865     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  8 in total

1.  Evidence for the role of PI(3) -kinase-AKT-eNOS signalling pathway in secondary inflammatory process after spinal cord compression injury in mice.

Authors:  Irene Paterniti; Emanuela Esposito; Emanuela Mazzon; Placido Bramanti; Salvatore Cuzzocrea
Journal:  Eur J Neurosci       Date:  2011-04       Impact factor: 3.386

2.  Basso Mouse Scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains.

Authors:  D Michele Basso; Lesley C Fisher; Aileen J Anderson; Lyn B Jakeman; Dana M McTigue; Phillip G Popovich
Journal:  J Neurotrauma       Date:  2006-05       Impact factor: 5.269

3.  Permeability at the blood-brain and blood-nerve barriers of the neurotrophic factors: NGF, CNTF, NT-3, BDNF.

Authors:  J F Poduslo; G L Curran
Journal:  Brain Res Mol Brain Res       Date:  1996-03

4.  Small molecule BDNF mimetics activate TrkB signaling and prevent neuronal degeneration in rodents.

Authors:  Stephen M Massa; Tao Yang; Youmei Xie; Jian Shi; Mehmet Bilgen; Jeffrey N Joyce; Dean Nehama; Jayakumar Rajadas; Frank M Longo
Journal:  J Clin Invest       Date:  2010-04-19       Impact factor: 14.808

5.  Rapid upregulation of caspase-3 in rat spinal cord after injury: mRNA, protein, and cellular localization correlates with apoptotic cell death.

Authors:  B A Citron; P M Arnold; C Sebastian; F Qin; S Malladi; S Ameenuddin; M E Landis; B W Festoff
Journal:  Exp Neurol       Date:  2000-12       Impact factor: 5.330

6.  Estrogen-induced Bcl-2 expression after spinal cord injury is mediated through phosphoinositide-3-kinase/Akt-dependent CREB activation.

Authors:  Tae Y Yune; Hong G Park; Jee Y Lee; Tae H Oh
Journal:  J Neurotrauma       Date:  2008-09       Impact factor: 5.269

Review 7.  Advances in stem cell therapy for spinal cord injury.

Authors:  Andrea J Mothe; Charles H Tator
Journal:  J Clin Invest       Date:  2012-11-01       Impact factor: 14.808

8.  Treadmill exercise reduces spinal cord injury-induced apoptosis by activating the PI3K/Akt pathway in rats.

Authors:  Sun-Young Jung; Dae-Young Kim; Tae Young Yune; Dong-Hoon Shin; Sang-Bin Baek; Chang-Ju Kim
Journal:  Exp Ther Med       Date:  2013-12-17       Impact factor: 2.447

  8 in total
  2 in total

Review 1.  Modulating Neurotrophin Receptor Signaling as a Therapeutic Strategy for Huntington's Disease.

Authors:  Danielle A Simmons
Journal:  J Huntingtons Dis       Date:  2017

2.  A small-molecule TrkB ligand restores hippocampal synaptic plasticity and object location memory in Rett syndrome mice.

Authors:  Wei Li; Alba Bellot-Saez; Mary L Phillips; Tao Yang; Frank M Longo; Lucas Pozzo-Miller
Journal:  Dis Model Mech       Date:  2017-07-01       Impact factor: 5.758

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.